Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation

Objective: to evaluate the safety of using 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution to develop acute renal injury (ARI) in patients after aortocoronary bypass surgery (ACBS) under extracorporeal circulation (EC). Subjects and methods. This was a single-center prospective, randomized, single...

Full description

Bibliographic Details
Main Authors: V. V. Lomivorotov, E. V. Fominsky, S. M. Efremov, V. A. Nepomnyashchikh, V. N. Lomivorotov, A. N. Shilova, A. M. Chernyavsky
Format: Article
Language:Russian
Published: Russian Academy of Medical Sciences 2013-10-01
Series:Obŝaâ Reanimatologiâ
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/98
id doaj-43df40b445684a0980c458fd97f5a154
record_format Article
spelling doaj-43df40b445684a0980c458fd97f5a1542021-07-28T21:21:54ZrusRussian Academy of Medical SciencesObŝaâ Reanimatologiâ1813-97792411-71102013-10-019510.15360/1813-9779-2013-5-3698Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal CirculationV. V. Lomivorotov0E. V. Fominsky1S. M. Efremov2V. A. Nepomnyashchikh3V. N. Lomivorotov4A. N. Shilova5A. M. Chernyavsky6Academician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationAcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationAcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationAcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationAcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationAcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationAcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian FederationObjective: to evaluate the safety of using 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution to develop acute renal injury (ARI) in patients after aortocoronary bypass surgery (ACBS) under extracorporeal circulation (EC). Subjects and methods. This was a single-center prospective, randomized, single-blind clinical trial. The patients singly received either 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution (a NC/HES group, n=20) or 0.9% NaCl (a control group, n=20) in a dose of 4 ml/kg for 30 min after induction of anesthesia. The primary endpoint was the rate of ARI diagnosed according to the recommendations of the International Organization KRIGO (Kidney Disease: Improving Global Outcomes). The secondary endpoints were serum cystatin C (sCys С), and urinary neutrophil gelatinase-associated lipocalin (uNGAL). Results. The rate of ARI was comparable in both patient groups. Thus, ARI was found in 4 (20%) patients in the NC/HES group and in 6 (30%) cases in the control group (p=0.72). During the first two postoperative days, the peak concentration of creatinine was significantly lower in the NC/HES group (101 (range 94—107) ^l/l) than in the control one (117 (range 100—127) ^l/l) (p=0.02). That of sCys C was substantially lower in the NC/HES group (0.83 (range 0.73—0.89) mg/l) than in the control one (1.02 (range 0.88—1.15) mg/l) (p=0.001). The patients of the NC/HES group had comparable peak of uNGAL concentrations (33 (range 5—38) ng/ml) versus the controls (30 (range 21—50) ng/ml). Conclusion. The use of NC/HES does not cause any increase in the rate of ARI, increased renal injury, or a more significant decrease in glomerular filtration in patients after ACBS under EC. Key words: hypertonic solution, hydroxyethyl starch, acute renal injury, aortocoronary bypass surgery.https://www.reanimatology.com/rmt/article/view/98hypertonic solutionhydroxyethyl starchacute renal injuryaortocoronary bypass surgery
collection DOAJ
language Russian
format Article
sources DOAJ
author V. V. Lomivorotov
E. V. Fominsky
S. M. Efremov
V. A. Nepomnyashchikh
V. N. Lomivorotov
A. N. Shilova
A. M. Chernyavsky
spellingShingle V. V. Lomivorotov
E. V. Fominsky
S. M. Efremov
V. A. Nepomnyashchikh
V. N. Lomivorotov
A. N. Shilova
A. M. Chernyavsky
Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation
Obŝaâ Reanimatologiâ
hypertonic solution
hydroxyethyl starch
acute renal injury
aortocoronary bypass surgery
author_facet V. V. Lomivorotov
E. V. Fominsky
S. M. Efremov
V. A. Nepomnyashchikh
V. N. Lomivorotov
A. N. Shilova
A. M. Chernyavsky
author_sort V. V. Lomivorotov
title Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation
title_short Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation
title_full Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation
title_fullStr Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation
title_full_unstemmed Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation
title_sort effect of 7.2% nacl/6% hydroxyethyl starch 200/0.5 solution on renal function during surgery under extracorporeal circulation
publisher Russian Academy of Medical Sciences
series Obŝaâ Reanimatologiâ
issn 1813-9779
2411-7110
publishDate 2013-10-01
description Objective: to evaluate the safety of using 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution to develop acute renal injury (ARI) in patients after aortocoronary bypass surgery (ACBS) under extracorporeal circulation (EC). Subjects and methods. This was a single-center prospective, randomized, single-blind clinical trial. The patients singly received either 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution (a NC/HES group, n=20) or 0.9% NaCl (a control group, n=20) in a dose of 4 ml/kg for 30 min after induction of anesthesia. The primary endpoint was the rate of ARI diagnosed according to the recommendations of the International Organization KRIGO (Kidney Disease: Improving Global Outcomes). The secondary endpoints were serum cystatin C (sCys С), and urinary neutrophil gelatinase-associated lipocalin (uNGAL). Results. The rate of ARI was comparable in both patient groups. Thus, ARI was found in 4 (20%) patients in the NC/HES group and in 6 (30%) cases in the control group (p=0.72). During the first two postoperative days, the peak concentration of creatinine was significantly lower in the NC/HES group (101 (range 94—107) ^l/l) than in the control one (117 (range 100—127) ^l/l) (p=0.02). That of sCys C was substantially lower in the NC/HES group (0.83 (range 0.73—0.89) mg/l) than in the control one (1.02 (range 0.88—1.15) mg/l) (p=0.001). The patients of the NC/HES group had comparable peak of uNGAL concentrations (33 (range 5—38) ng/ml) versus the controls (30 (range 21—50) ng/ml). Conclusion. The use of NC/HES does not cause any increase in the rate of ARI, increased renal injury, or a more significant decrease in glomerular filtration in patients after ACBS under EC. Key words: hypertonic solution, hydroxyethyl starch, acute renal injury, aortocoronary bypass surgery.
topic hypertonic solution
hydroxyethyl starch
acute renal injury
aortocoronary bypass surgery
url https://www.reanimatology.com/rmt/article/view/98
work_keys_str_mv AT vvlomivorotov effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
AT evfominsky effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
AT smefremov effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
AT vanepomnyashchikh effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
AT vnlomivorotov effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
AT anshilova effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
AT amchernyavsky effectof72nacl6hydroxyethylstarch20005solutiononrenalfunctionduringsurgeryunderextracorporealcirculation
_version_ 1721259794825740288